FMR LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 35 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$9,522,060
+12.4%
6,040,0000.0%0.00%0.0%
Q3 2022$8,474,000
+27.6%
6,040,000
+19.8%
0.00%0.0%
Q2 2022$6,640,000
+0.6%
5,040,0000.0%0.00%0.0%
Q1 2022$6,602,000
+5.1%
5,040,0000.0%0.00%
Q4 2021$6,284,000
-6.0%
5,040,0000.0%0.00%
-100.0%
Q3 2021$6,682,000
-17.3%
5,040,000
-16.6%
0.00%0.0%
Q2 2021$8,075,000
-0.6%
6,040,0000.0%0.00%0.0%
Q1 2021$8,120,000
-2.6%
6,040,0000.0%0.00%0.0%
Q4 2020$8,334,000
-15.7%
6,040,000
-16.0%
0.00%0.0%
Q3 2020$9,886,000
-21.7%
7,190,000
-5.3%
0.00%0.0%
Q2 2020$12,620,000
+29.7%
7,590,0000.0%0.00%0.0%
Q1 2020$9,727,000
-29.5%
7,590,000
-15.8%
0.00%
-50.0%
Q4 2019$13,805,000
+17.0%
9,015,000
+4.6%
0.00%
+100.0%
Q3 2019$11,796,000
-15.9%
8,615,000
-19.4%
0.00%
-50.0%
Q2 2019$14,025,000
-2.9%
10,690,000
-0.0%
0.00%0.0%
Q1 2019$14,449,000
+97.4%
10,692,000
+74.4%
0.00%
+100.0%
Q4 2018$7,318,000
-39.8%
6,130,000
-14.0%
0.00%0.0%
Q3 2018$12,154,0007,130,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders